Axel Kahn
#126,362
Most Influential Person Now
Axel Kahn's AcademicInfluence.com Rankings
Axel Kahnphilosophy Degrees
Philosophy
#5934
World Rank
#8871
Historical Rank
Logic
#3137
World Rank
#4254
Historical Rank
Download Badge
Philosophy
Why Is Axel Kahn Influential?
(Suggest an Edit or Addition)Axel Kahn's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. (2002) (1570)
- Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice (2001) (1273)
- Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. (1998) (1095)
- Doublecortin Is a Developmentally Regulated, Microtubule-Associated Protein Expressed in Migrating and Differentiating Neurons (1999) (981)
- Severe iron deficiency anemia in transgenic mice expressing liver hepcidin (2002) (927)
- A Novel CNS Gene Required for Neuronal Migration and Involved in X-Linked Subcortical Laminar Heterotopia and Lissencephaly Syndrome (1998) (735)
- Transcription of the dystrophin gene in human muscle and non-muscle tissues (1988) (713)
- Illegitimate transcription: transcription of any gene in any cell type. (1989) (634)
- Transfer of a foreign gene into the brain using adenovirus vectors (1993) (535)
- The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. (2003) (503)
- Apc tumor suppressor gene is the "zonation-keeper" of mouse liver. (2006) (480)
- Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation (1998) (466)
- Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice (1993) (411)
- Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice (1996) (398)
- New targets of β-catenin signaling in the liver are involved in the glutamine metabolism (2002) (387)
- Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. (2005) (379)
- Hepcidin, a new iron regulatory peptide. (2002) (342)
- Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. (2004) (336)
- Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis (2003) (318)
- Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine (2005) (310)
- Corticosteroid-dependent sodium transport in a novel immortalized mouse collecting duct principal cell line. (1999) (304)
- A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation (1999) (290)
- Glucose Regulation of Gene Transcription* (2000) (275)
- A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation (2000) (244)
- Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the β-catenin gene (2001) (242)
- Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site. (1998) (235)
- Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. (2006) (232)
- Role of AMP-activated protein kinase in the regulation by glucose of islet beta cell gene expression. (2000) (221)
- Immunochemical Characterization and Transacting Properties of Upstream Stimulatory Factor Isoforms (*) (1996) (206)
- Long–term correction of mouse dystrophic degeneration by adenovirus–mediated transfer of a minidystrophin gene (1993) (202)
- Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry. (1985) (202)
- Quantitative estimation of minor mRNAs by cDNA-polymerase chain reaction. Application to dystrophin mRNA in cultured myogenic and brain cells. (1990) (192)
- Transcriptional control of metabolic regulation genes by carbohydrates (1994) (189)
- Bcl-2 and Bax modulate adenine nucleotide translocase activity. (2003) (181)
- Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes (1998) (176)
- LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. (1999) (176)
- Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4 (1997) (175)
- Cis-regulation of the L-type pyruvate kinase gene promoter by glucose, insulin and cyclic AMP. (1992) (159)
- Dystrophin gene transcribed from different promoters in neuronal and glial cells (1990) (158)
- Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies (1990) (154)
- On the evolutionary conservation of the cell death pathway: mitochondrial release of an apoptosis-inducing factor during Dictyostelium discoideum cell death. (2001) (152)
- Hepatomegaly in Transgenic Mice Expressing an Oncogenic Form of β-Catenin (2001) (151)
- Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit. (2004) (150)
- The 5′‐AMP‐activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex (1998) (150)
- Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in nonmuscle tissues. (1992) (149)
- Transimmortalized mouse intestinal cells (m-ICc12) that maintain a crypt phenotype. (1996) (148)
- Essential Role in Vivo of Upstream Stimulatory Factors for a Normal Dietary Response of the Fatty Acid Synthase Gene in the Liver* (1999) (146)
- Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response. (1995) (141)
- Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation. (2000) (140)
- Transcriptional Glucose Signaling through The Glucose Response Element Is Mediated by the Pentose Phosphate Pathway (*) (1996) (140)
- Hepatocyte Nuclear Factor-4α Involved in Type 1 Maturity-Onset Diabetes of the Young Is a Novel Target of AMP-Activated Protein Kinase (2001) (138)
- Characterization of proopiomelanocortin transcripts in human nonpituitary tissues. (1987) (136)
- Regulation of the expression of the L-type pyruvate kinase gene in adult rat hepatocytes in primary culture. (1989) (135)
- Differential Roles of Upstream Stimulatory Factors 1 and 2 in the Transcriptional Response of Liver Genes to Glucose* (1998) (134)
- Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. (1994) (133)
- Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome. (1991) (131)
- Identification of the IFITM family as a new molecular marker in human colorectal tumors. (2006) (130)
- Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice. (2005) (125)
- Pulmonary Surfactant Protein A (SP-A) Is Expressed by Epithelial Cells of Small and Large Intestine (*) (1995) (125)
- Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas' heart disease. (1989) (124)
- Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. (1999) (123)
- Functional differences between hepcidin 1 and 2 in transgenic mice. (2004) (122)
- Bone marrow transplantation in mice leads to a minor population of hepatocytes that can be selectively amplified in vivo (2002) (122)
- Growth and differentiation of C2 myogenic cells are dependent on serum response factor (1996) (117)
- Expression of the transferrin gene during development of non-hepatic tissues: high level of transferrin mRNA in fetal muscle and adult brain. (1984) (117)
- The pyruvate kinase gene as a model for studies of glucose-dependent regulation of gene expression in the endocrine pancreatic beta-cell type. (1993) (116)
- Transcriptional and post-transcriptional regulation of L-type pyruvate kinase gene expression in rat liver. (1986) (115)
- Proteins binding to the liver-specific pyruvate kinase gene promoter. A unique combination of known factors. (1989) (113)
- Upstream Stimulatory Factor Proteins Are Major Components of the Glucose Response Complex of the L-type Pyruvate Kinase Gene Promoter (*) (1995) (110)
- Glucose-dependent Liver Gene Expression in Upstream Stimulatory Factor 2 −/− Mice* (1997) (109)
- Functional characterization of the L-type pyruvate kinase gene glucose response complex (1993) (108)
- Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy. (2003) (105)
- Cloning and expression of cDNA for anti-müllerian hormone. (1986) (102)
- Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. (2001) (99)
- Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice. (2001) (95)
- Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice. (2006) (94)
- Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. (1991) (93)
- The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver (2002) (90)
- Gene delivery into the central nervous system by nasal instillation in rats. (1995) (90)
- Respective roles of glucose, fructose, and insulin in the regulation of the liver-specific pyruvate kinase gene promoter. (1994) (88)
- A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease. (1990) (86)
- Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts. (1996) (81)
- High tyrosine kinase activity in normal nonproliferating cells (1983) (79)
- The genetic system of the L-type pyruvate kinase forms in man. Subunit structure, interrelation and kinetic characteristics of the pyruvate kinase enzymes from erythrocytes and liver. (1978) (78)
- A combination of MEF3 and NFI proteins activates transcription in a subset of fast-twitch muscles (1997) (77)
- Illegitimate transcription: Its use in the study of inherited disease (1992) (75)
- Upstream Stimulatory Factor-2 (USF2) Activity Is Required for Glucose Stimulation of L-Pyruvate Kinase Promoter Activity in Single Living Islet β-Cells* (1997) (75)
- Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries. (1985) (75)
- Transcriptional regulation by glucose in the liver. (1997) (73)
- A tamoxifen‐inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver (2002) (73)
- One gene, but two messenger RNAs encode liver L and red cell L′ pyruvate kinase subunits (1981) (72)
- Molecular cloning of cDNA for rat L-type pyruvate kinase and aldolase B. (1983) (70)
- Non-specific X-linked semidominant mental retardation by mutations in a Rab GDP-dissociation inhibitor. (1998) (70)
- Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase. (2001) (69)
- Expression of the gene for anti-Müllerian hormone. (1990) (69)
- Posttranslational modifications of enzymes. (1978) (68)
- Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: Therapeutic effects and mechanisms of action (1998) (67)
- Intestinal Expression of the Calbindin-D9K Gene in Transgenic Mice (1998) (66)
- Adenoviral Vector as a Gene Delivery System into Cultured Rat Neuronal and Glial Cells (1993) (65)
- Expression of MyoD1 coincides with terminal differentiation in determined but inducible muscle cells. (1989) (65)
- Adenoviral gene therapy of the Tay-Sachs disease in hexosaminidase A-deficient knock-out mice. (1999) (64)
- Transferrin gene expression in choroid plexus of the adult rat brain (1987) (64)
- Characterization of three optional promoters in the 5' region of the human aldolase A gene. (1987) (63)
- Iron‐ and inflammation‐induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo (2005) (63)
- Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy. (1999) (62)
- Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice. (1999) (62)
- Cell-free translation of messenger RNAs from adult and fetal human muscle. Characterization of neosynthesized glycogen phosphorylase, phosphofructokinase and glucose phosphate isomerase. (1981) (61)
- In vivo hormonal control of L-type pyruvate kinase gene expression. Effects of glucagon, cyclic AMP, insulin, cortisone, and thyroid hormones on the dietary induction of mRNAs in the liver. (1984) (61)
- Isolation and characterization of cDNA clones for human skeletal muscle α actin (1983) (61)
- Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice. (1999) (61)
- Adenoviral and adeno-associated viral vector mediated gene transfer in the guinea pig cochlea (2002) (61)
- Glucose‐dependent regulation of the l‐pyruvate kinase gene in a hepatoma cell line is independent of insulin and cyclic AMP (1994) (60)
- Conditional cell ablation by tight control of caspase-3 dimerization in transgenic mice (2002) (59)
- In vivo electrotransfer of the cardiotrophin-1 gene into skeletal muscle slows down progression of motor neuron degeneration in pmn mice. (2002) (59)
- Exploration of a liver-specific, glucose/insulin-responsive promoter in transgenic mice. (1993) (59)
- Establishment of renal proximal tubule cell lines by targeted oncogenesis in transgenic mice using the L-pyruvate kinase-SV40 (T) antigen hybrid gene. (1993) (59)
- Human erythrocyte pyruvate kinase. Total purification and evidence for its antigenic identity with L-type enzyme. (1977) (56)
- Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients. (1991) (56)
- Gene expression in hepatocyte-like lines established by targeted carcinogenesis in transgenic mice. (1992) (56)
- Glucose-stimulated genes and prospects of gene therapy for type I diabetes. (1997) (56)
- Evidence for a postsynthetic proteolytic transformation of human erythrocyte pyruvate kinase into L‐type enzyme (1977) (54)
- Four new mutations in the NADH-cytochrome b5 reductase gene from patients with recessive congenital methemoglobinemia type II. (1995) (54)
- Diet-dependent carcinogenesis of pancreatic islets and liver in transgenic mice expressing oncogenes under the control of the L-type pyruvate kinase gene promoter. (1992) (54)
- Structure of the rat L-type pyruvate kinase gene. (1987) (54)
- Therapeutic liver repopulation in a mouse model of hypercholesterolemia. (2000) (53)
- The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2. (1984) (53)
- Dominant X linked subcortical laminar heterotopia and lissencephaly syndrome (XSCLH/LIS): evidence for the occurrence of mutation in males and mapping of a potential locus in Xq22. (1997) (53)
- Chicken Ovalbumin Upstream Promoter-Transcription Factor II, a New Partner of the Glucose Response Element of the L-type Pyruvate Kinase Gene, Acts as an Inhibitor of the Glucose Response* (1999) (53)
- Complete nucleotide and deduced amino acid sequences of rat L‐type pyruvate kinase (1986) (52)
- Competition between transcription factors HNF1 and HNF3, and alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase B promoter. (1993) (52)
- Determinants of the brain-specific expression of the rat aldolase C gene: ex vivo and in vivo analysis. (1993) (52)
- Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice. (2004) (51)
- Overproduction of a truncated hepatocyte nuclear factor 3 protein inhibits expression of liver-specific genes in hepatoma cells (1995) (51)
- Fast-muscle-specific DNA-protein interactions occurring in vivo at the human aldolase A M promoter are necessary for correct promoter activity in transgenic mice (1996) (50)
- Oligophrenin 1 encodes a rho-GAP protein involved in X-linked mental retardation. (1998) (50)
- Glucose-dependent and -independent effect of insulin on gene expression. (1991) (48)
- Dietary and hormonal regulation of aldolase B gene expression. (1985) (48)
- Interplay of an original combination of factors: C/EBP, NFY, HNF3, and HNF1 in the rat aldolase B gene promoter. (1991) (48)
- Elements responsible for hormonal control and tissue specificity of L-type pyruvate kinase gene expression in transgenic mice (1992) (48)
- Bcl-2 targeted overexpression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors. (1997) (47)
- The 'CC.Ar.GG' box. A protein-binding site common to transcription-regulatory regions of the cardiac actin, c-fos and interleukin-2 receptor genes. (1988) (46)
- Post-translational modifications of human glucose-6-phosphate dehydrogenase. (1975) (46)
- Somatic mutations of the b -catenin gene are frequent in mouse and human hepatocellular carcinomas (1998) (46)
- Fluorescence-assisted mismatch analysis (FAMA) for exhaustive screening of the α-galactosidase A gene and detection of carriers in Fabry disease (1996) (45)
- Characterization of the Aldolase B Intronic Enhancer* (1998) (44)
- RT-PCR and mRNA Quantitation (1994) (43)
- Molecular cloning and sequence analysis of cDNA for human transferrin. (1984) (43)
- Essential role of chicken ovalbumin upstream promoter-transcription factor II in insulin secretion and insulin sensitivity revealed by conditional gene knockout. (2005) (43)
- Therapeutic benefit of ciliary neurotrophic factor in progressive motor neuronopathy depends on the route of delivery (1999) (43)
- Fast-muscle-specific expression of human aldolase A transgenes. (1994) (42)
- Variable modes of proopiomelanocortin gene transcription in human tumors. (1989) (41)
- [23] Pyruvate kinases from human erythrocytes and liver (1982) (41)
- Dietary control of aldolase B and L-type pyruvate kinase mRNAs in rat. Study of translational activity and hybridization with cloned cDNA probes. (1984) (41)
- Adenovirus-mediated transfer of the acid alpha-glucosidase gene into fibroblasts, myoblasts and myotubes from patients with glycogen storage disease type II leads to high level expression of enzyme and corrects glycogen accumulation. (1998) (41)
- Role of the GLUT 2 Glucose Transporter in the Response of the L-type Pyruvate Kinase Gene to Glucose in Liver-derived Cells* (1997) (41)
- Clone mammals... clone man? (1997) (40)
- Exhaustive screening of the acid beta-glucosidase gene, by fluorescence-assisted mismatch analysis using universal primers: mutation profile and genotype/phenotype correlations in Gaucher disease. (1998) (40)
- Cyclic AMP as a transcriptional inhibitor of upper eukaryotic gene transcription. (1984) (40)
- Positive and negative regulatory DNA elements including a CCArGG box are involved in the cell type-specific expression of the human muscle dystrophin gene. (1992) (40)
- Purification and partial characterization of different forms of phosphofructokinase in man. (1979) (39)
- Functional properties of proximal tubule cell lines derived from transgenic mice harboring L-pyruvate kinase-SV40 (T) antigen hybrid gene. (1993) (39)
- Mapping of the X-Breakpoint Involved in a Balanced X;12 Translocation in a Female with Mild Mental Retardation (1997) (39)
- Lymphoepithelial Interactions Trigger Specific Regulation of Gene Expression in the M Cell-Containing Follicle-Associated Epithelium of Peyer’s Patches1 (2002) (39)
- Deletion of the long arm of the Y chromosome and review of Y chromosome abnormalities. (1985) (38)
- CC Ar GG boxes, cis-acting elements with a dual specificity. Muscle-specific transcriptional activation and serum responsiveness. (1990) (38)
- Expression of COUP-TFII in metabolic tissues during development (2002) (38)
- γ-Ray irradiation induces B7.1 costimulatory molecule neoexpression in various murine tumor cells (1998) (38)
- Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer. (1996) (37)
- Analysis by cell-free transcription of the liver-specific pyruvate kinase gene promoter (1989) (37)
- Expression of the rat L-type pyruvate kinase gene from its dual erythroid- and liver-specific promoter in transgenic mice. (1989) (36)
- In vivo developmental modifications of the expression of genes encoding muscle-specific enzymes in rat. (1986) (36)
- Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis. (1987) (36)
- An opportunistic promoter sharing regulatory sequences with either a muscle-specific or a ubiquitous promoter in the human aldolase A gene (1993) (35)
- Chronic haemolytic anaemia in two patients heterozygous for erythrocyte pyruvate kinase deficiency. Electrofocusing and immunological studies of erythrocyte and liver pyruvate kinase. (2009) (35)
- In vivo regulation of glycolytic and gluconeogenic enzyme gene expression in newborn rat liver. (1988) (35)
- Structure, sequence, and chromosomal location of the gene for USF2 transcription factors in mouse. (1995) (35)
- Assignment of the ǵene for F‐type phosphofructokinase to human chromosome 10 by somatic cell hybridization and specific immunoprecipitation (1980) (34)
- Gene for nonspecific X-linked mental retardation (MRX 47) is located in Xq22.3-q24. (1997) (34)
- cis-acting DNA elements regulating expression of the liver pyruvate kinase gene in hepatocytes and hepatoma cells. Evidence for tissue-specific activators and extinguisher. (1991) (34)
- Transfection of hepatic genes into adult rat hepatocytes in primary culture and their tissue-specific expression. (1989) (34)
- Regulation of genes for glycolytic enzymes in cultured rat hepatoma cell lines. (1987) (33)
- Phosphofructokinase in human blood cells. (1979) (33)
- Muscle as a putative producer of acid α-glucosidase for glycogenosis type II gene therapy (2002) (32)
- The structural gene for aldolase B (ALDB) maps to 9q13→32 (1985) (32)
- Estradiol-dependent uterine leiomyomas in transgenic mice. (1996) (32)
- Proopiomelanocortin gene expression in normal and tumoral human lung. (1991) (32)
- The brain-specific gene for rat aldolase C possesses an unusual housekeeping-type promoter. (1989) (31)
- Myotube-specific activity of the human aldolase A M-promoter requires an overlapping binding site for NF1 and MEF2 factors in addition to a binding site (M1) for unknown proteins. (1995) (31)
- L-type pyruvate kinase from human liver. Purification by double affinity elution, electrofocusing and immunological studies. (1976) (31)
- Characterization of human red blood cell tyrosine kinase. (1985) (29)
- Erythrocyte phosphofructokinase deficiency associated with an unstable variant of muscle phosphofructokinase. (1975) (29)
- Activity of the rat liver-specific aldolase B promoter is restrained by HNF3. (1994) (29)
- Influence of the content in transcription factors on the phenotype of mouse hepatocyte-like cell lines (mhAT). (1993) (29)
- Differential effects of glucose and fructose on liver L-type pyruvate kinase gene expression in vivo. (1987) (29)
- Liver repopulation by Bcl-x(L) transgenic hepatocytes. (2002) (29)
- The structural gene for transferrin (TF) maps to 3q21----3qter. (1984) (28)
- Identification by STS PCR screening of a microdeletion in Xp21.3-22.1 associated with non-specific mental retardation. (1996) (28)
- An Intronic Enhancer Essential for Tissue-specific Expression of the Aldolase B Transgenes (*) (1996) (28)
- Molecular cloning and expression of rat aldolase C messenger RNA during development and hepatocarcinogenesis. (1987) (27)
- Transcription factors and aldolase B gene expression in microdissected renal proximal tubules and derived cell lines. (1995) (27)
- Nucleotide sequence of a cDNA clone for human aldolase B. (1983) (26)
- Analysis of fibrinogen genes in patients with congenital afibrinogenemia. (1984) (26)
- Tyrosine kinases in normal human blood cells (1986) (26)
- Endogenous, cyclic 3'-5' AMP-dependent phosphorylation of human red cell pyruvate kinase. (1979) (26)
- Characterization of the rat pulmonary surfactant protein A promoter. (1992) (26)
- Detection of mRNAs present at low concentrations in rat liver by in situ hybridization: application to the study of metabolic regulation and azo dye hepatocarcinogenesis. (1987) (25)
- Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients. (1993) (25)
- Metachromatic leukodystrophy: Identification of the first deletion in exon 1 and nine novel point mutations in the arylsulfatase A gene (1997) (25)
- Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions. (1996) (25)
- Of mice and men: the iron age. (2005) (25)
- Possible molecular mechanisms of ageing. (1977) (24)
- In vivo effects of activated H‐ras oncogene expressed in the liver and in urogenital tissues (1997) (24)
- Protein kinases in human leukemic cells (1985) (24)
- In vivo transfer of a marker gene to study motoneuronal development. (1994) (24)
- Proteolytic processing of human erythrocyte pyruvate kinase : study of normal and deficient enzymes. (1979) (23)
- Cell-Free Translation of Messenger RNAs from Human Muscle Biopsies: a Miniaturized Tool for Investigation of Neuromuscular Diseases (1982) (22)
- Targeted oncogenesis: A powerful method to derive renal cell lines. (1995) (22)
- Modifications of purified glucose-6-phosphate dehydrogenase and other enzymes by a factor of low molecular weight abundant in some leukemic cells. (1976) (22)
- Two different species of messenger RNAs specify synthesis of M1 and M2 pyruvate kinase subunits. (1982) (22)
- Transcriptional and translational mechanisms of cytochrome b5 reductase isoenzyme generation in humans. (2001) (22)
- Immunologie Study of the Age-related Loss of Activity of Six Enzymes in the Red Cells from Newborn Infants and Adults — Evidence for a Fetal Type of Erythrocyte Phosphofructokinase (1977) (22)
- Effect of different basic helix-loop-helix leucine zipper factors on the glucose response unit of the L-type pyruvate kinase gene. (1998) (22)
- Studies on the nature of different molecular forms of glucose-6-phosphate dehydrogenase purified from human leukocytes. (1976) (22)
- Evidence for structural differences between human glucose-6-phosphate dehydrogenase purified from leukocytes and erythrocytes. (1977) (22)
- Illegitimate (or ectopic) transcription proceeds through the usual promoters. (1991) (22)
- Fas/CD95 pathway induces mouse liver regeneration and allows for highly efficient retrovirus‐mediated gene transfer (2001) (22)
- Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice. (1999) (22)
- Pyruvate kinases from human erythrocytes and liver. (1982) (21)
- Heat lability of glucose-6-phosphate dehydrogenase in some senescent human cultured cells. Evidence for its postsynthetic nature. (1977) (21)
- Phosphorylation of Human Erythrocyte Pyruvate Kinase by Soluble Cyclic-AMP-Dependend Protein Kinases (1980) (21)
- Analysis of a brain-specific isozyme. Expression and chromatin structure of the rat aldolase C gene and transgenes. (1994) (21)
- Causal mechanisms of multiple acquired red cell enzyme defects in a patient with acquired dyserythropoiesis. (1976) (20)
- The red-green visual pigment gene region in adrenoleukodystrophy. (1990) (20)
- A ubiquitous enhancer shared by two promoters in the human aldolase A gene. (1991) (20)
- Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients (1993) (20)
- Molecular studies of liver aldolase B in hereditary fructose intolerance using blotting and immunological techniques (1982) (20)
- Phosphofructokinase (PFK) isozymes in man (1979) (19)
- In Vivo Functional Characterization of the Aldolase B Gene Enhancer* (2002) (19)
- The serum response factor (SRF) is needed for muscle-specific activation of CArG boxes. (1996) (19)
- Pituitary-like proopiomelanocortin transcripts in human Leydig cell tumors. (1990) (19)
- Characterization of messenger RNA for aldolase B in adult and fetal human liver. (1982) (19)
- Acquired red cell pyruvate kinase deficiency in leukemias and related disorders. (1975) (18)
- Expression of the rat aldolase B gene: a liver-specific proximal promoter and an intronic activator. (1991) (18)
- Muscle as a putative producer of acid alpha-glucosidase for glycogenosis type II gene therapy. (2002) (18)
- Activity and inducibility of drug-metabolizing enzymes in immortalized hepatocyte-like cells (mhPKT) derived from a L-PK/Tag1 transgenic mouse. (1997) (18)
- Role of AMP-activated protein kinase in the regulation of gene transcription. (2001) (18)
- Glucose responsiveness of a reporter gene transduced into hepatocytic cells using a retroviral vector (1995) (18)
- Glucose-phosphate isomerase deficiency due to a new variant (GP I Barcelona) and to a silent gene: biochemical, immunological and genetic studies. (1976) (18)
- Genetic and epigenetic control of the pyruvate kinase isozymes in mammals. (1983) (18)
- Purification of L-type pyruvate kinase from human liver by affinity chromatography on Blue-Dextran-Sepharose column. (1977) (18)
- Retrovirus-mediated enzymatic correction of Tay-Sachs defect in transduced and non-transduced cells. (1998) (17)
- Mechanisms of the acquired erythrocyte enzyme deficiencies in blood diseases. (1976) (17)
- In vitro and in vivo protein--DNA interactions on the rat erythroid-specific L' pyruvate kinase gene promoter. (1992) (17)
- 5'-Flanking and Intragenic Sequences Confer Androgenic and Developmental Regulation of Mouse Aldose Reductase-Like Gene in Vas Deferens and Adrenal in Transgenic Mice. (1999) (17)
- Skipping of exon 5 as a consequence of the 711 + 1 G-->T mutation in the CFTR gene. (1992) (17)
- Upstream Elements Involved in Vivo in Activation of the Brain-specific Rat Aldolase C Gene (1998) (17)
- Regulation of the multiple promoters of the human aldolase A gene: response of its two ubiquitous promoters to agents promoting cell proliferation. (1991) (17)
- Functional and growth properties of a myometrial cell line derived from transgenic mice: effects of estradiol and antiestrogens. (1996) (17)
- Retroviral infection of primary hepatocytes from normal mice and mice transgenic for SV40 large T antigen. (1993) (16)
- Pyruvate kinase isozymes in man (1976) (16)
- Expression of the transcripts initiated in the 62nd intron of the dystrophin gene (1993) (16)
- A gene for dominant nonspecific X-linked mental retardation is located in Xq28. (1997) (16)
- Aging and accuracy of protein synthesis in man: search for inactive enzymatic cross-reacting material in granulocytes of aged people. (1976) (15)
- Tissue-specific heterogeneity of the 3'-untranslated region of L-type pyruvate kinase mRNAs. (1986) (15)
- Identification and Functional Characterization of an Erythroid-specific Enhancer in the L-type Pyruvate Kinase Gene (*) (1995) (15)
- Hereditary erythrocyte pyruvate kinase deficiency: molecular and functional studies of four mutant PK variants detected in Spain. (1977) (14)
- Expression of the dystrophin gene in cultured fibroblasts. (1993) (14)
- Modifications of phosphoproteins and protein kinases occurring with in vitro aging of cultured human cells. (1982) (14)
- Proximal Sequences of the Aldolase A Fast Muscle-specific Promoter Direct Nerve- and Activity-dependent Expression in Transgenic Mice* (1998) (14)
- Expression of aldolase A messenger RNAs in human adult and foetal tissues and in hepatoma. (1986) (14)
- Determination of the gene structure of human oligophrenin-1 and identification of three novel polymorphisms by screening of DNA from 164 patients with non-specific X-linked mental retardation. (2000) (14)
- Inherited microdeletion in Xp21.3–22.1 involved in non‐specific mental retardation (1998) (14)
- Sequences complementary to the brain-specific "identifier" sequences exist in L-type pyruvate kinase mRNA (a liver-specific messenger) and in transcripts especially abundant in muscle. (1986) (14)
- Post translational modifications of glucose-6-phosphate dehydrogenase in human leukemias. (1975) (14)
- Isozyme shift in cultured fetal human hepatocytes: a study of pyruvate kinase and phosphofructokinase. (1980) (13)
- Gd(-) Abrami a deficient G-6PD variant with hemizygous expression in blood cells of a woman with primary myelofibrosis (1975) (13)
- Does preventive vaccination with engineered tumor cells work in cancer-prone transgenic mice? (1998) (13)
- Transient transcriptional inhibition of the transferrin gene by cyclic AMP (1985) (13)
- Pyruvate Kinase and Phosphofructokinase Isozymes in Childhood Cancers (1982) (13)
- Pro-opiomelanocortin gene expression in human phaeochromocytomas. (1989) (13)
- Purification of F4 phosphofructokinase from human platelets and comparison with the other phosphofructokinase forms. (1980) (13)
- Pyruvate kinase isozymes in man (1976) (13)
- Characterization of a highly complex region in Xq13 and mapping of three isodicentric breakpoints associated with preleukemia. (2000) (13)
- Novel Target Sequences for Pax-6 in the Brain-specific Activating Regions of the Rat Aldolase C Gene* (2002) (12)
- Molecular mechanism of glucose-6-phosphate dehydrogenase deficiency (2004) (12)
- Dietary and hormonal regulation of L-type pyruvate kinase gene expression in rat small intestine. (1987) (12)
- GD (-) Aachen, a new variant of deficient glucose-6-phosphate dehydrogenase (1976) (12)
- Cell free synthesis of human prothrombin: immunological characterization of the translation product. (1981) (12)
- Differences in the two red-cell populations in erythroleukaemia. (1971) (12)
- Gd(minus)Matam, an African glucose-6-phosphate dehydrogenase variant with enzyme deficiency. Biochemical and immunological properties in various hemopoietic tissues. (1975) (12)
- Cotranslation of L and L' pyruvate kinase messenger RNAs from human fetal liver. (1982) (12)
- Protein kinases of rat liver during hepatocarcinogenesis induced by an azo dye. (1983) (12)
- A Spanish family with erythrocyte pyruvate kinase deficiency: contribution of various immunologic methods in the study of the mutant enzyme. (1977) (12)
- Glucose-6-phosphate dehydrogenase slow variant with deficiency in a Spanish family. Relationship with the Gd (minus) Seattle variant. (1974) (12)
- Human erythrocyte phosphoglycerate kinase deficiency: presence in a deficient patient of a stable variant with lowered catalytic activity. (1976) (12)
- Genetic and Molecular Mechanisms of the Congenital Defects in Glucose Phosphate Isomerase Activity: Studies of Four Families (1977) (12)
- Isozyme pattern in serially xenotransplanted childhood tumors. (1984) (11)
- Expression of c-myc is under dietary control in rat liver. (1987) (11)
- Human granulocyte 6 phosphogluconate dehydrogenase. Purification by elective elution with NADP+, immunological and kinetic properties. (1975) (11)
- Heterogeneity of the rat NADH-cytochrome-b5-reductase transcripts resulting from multiple alternative first exons. (1994) (11)
- Isolation and characterization of cDNA clones for human skeletal muscle alpha actin. (1983) (11)
- A Binding Site for Nuclear Receptors Is Required for the Differential Expression of the Aldolase A Fast-twitch Muscle Promoter in Body and Head Muscles* (1998) (11)
- Advances in hereditary red cell enzyme abnormalities. (1979) (11)
- DNase-I hypersensitivity analysis of the L-type pyruvate kinase gene in rats and transgenic mice. (1992) (11)
- Molecular mechanism of erythrocyte pyruvate kinase deficiency (1975) (11)
- Collaborative Study of the Molecular Epidemiology of Tay-Sachs Disease in Europe (1993) (11)
- Modifications of the expression of liver-specific and non-specific messenger RNAs during azo-dye hepatocarcinogenesis. (1985) (11)
- Glucose phosphate isomerase deficiency with hereditary hemolytic anemia in a Spanish family: Clinical and familial studies (1975) (11)
- Adenovirus-mediated transfer of a human dystrophin gene to skeletal muscle of mdx mouse. (1994) (10)
- Fiber-type specific and position-dependent expression of a transgene in limb muscles. (2002) (10)
- Glycogen-storage disease type II (acid maltase deficiency): identification of a novel small deletion (delCC482+483) in French patients. (1997) (10)
- Proteolytic processing of human L-type pyruvate kinase increases its ability to be phosphorylated. (1980) (10)
- Fructose‐1,6‐diphosphate binding by two forms of pyruvate kinase purified from human erythrocytes (1977) (10)
- Mouse USF1 gene cloning: comparative organization within the c-myc gene family (1996) (10)
- Muscle phosphofructokinase deficiency in man: expression of the defect in blood cells and cultured fibroblasts (1981) (10)
- Developmental regulation of the aldolase A muscle-specific promoter during in vivo muscle maturation is controlled by a nuclear receptor binding element. (1999) (10)
- Induction of glycolytic enzyme synthesis in proliferating fibroblasts. Study of phosphofructokinase, glucose phosphate isomerase and pyruvate kinase. (1983) (9)
- [Values and limits of adenoviral vectors for gene transfer in vivo]. (1993) (9)
- CFTR illegitimate transcription in lymphoid cells: quantification and applications to the investigation of pathological transcripts (1992) (9)
- Human leukocyte glucose-phosphate-isomerase purification by affinity elution and immunological study. (1976) (9)
- [Phenotypes of erythrocytic glucose-6-phosphate dehydrogenase in black people. Examination of 301 black people living in France and description of 9 different variants. High incidence of deficiency of an enzyme of "B" mobility]. (1973) (9)
- Molecular and functional anomalies in two new mutant glucose-phosphate-isomerase variants with enzyme deficiency and chronic hemolysis (1978) (9)
- Phosphofructokinase in Human Fetus (1980) (8)
- Hyperanodic forms of human glucose-6-phosphate dehydrogenase. (1978) (8)
- X-linked neurodegenerative syndrome with congenital ataxia, late-onset progressive myoclonic encephalopathy and selective macular degeneration, linked to Xp22.33-pter. (1996) (8)
- Human platelet glucose-6-phosphate dehydrogenase. Total purification, kinetic studies and relationship with enzyme from other blood cells. (1976) (8)
- Phospho ADP ribosylation of human glucose 6 phosphate dehydrogenase: probable mechanism of the occurrence of hyperanodic forms. (1979) (8)
- Endogenous phosphorylation of soluble enzymes in human red cells. Cyclic 3',5'-AMP-dependent phosphorylation of phosphofructokinase without detectable regulatory effect. (1980) (8)
- Favism in a Portuguese family due to a deficient glucose-phosphate dehydrogenase variant (Canton) or (cpanton-like) type. (1976) (8)
- Long-term histological follow-up of genetically modified myoblasts grafted into the brain. (1997) (7)
- Combinatorial crosstalk of transacting factors binding to the L-type pyruvate kinase promoter elements analysed in vitro. (1992) (7)
- Protein kinases in normal human blood cells (1983) (7)
- RT-PCR and Gene Expression (1994) (7)
- Significance of the electrophoretic modifications of defective pyruvate kinase variants. Study of six new observations. (1979) (7)
- In vivo effects of activated H-ras oncogene expressed in the liver and in urogenital tissues. (1997) (7)
- Absence of functional messenger RNA for glycogen phosphorylase in the muscle of two patients with McArdle's disease (1983) (6)
- Molecular organization of human L' and L pyruvate kinases. (1982) (6)
- Activation of gene expression via CArG boxes during myogenic differentiation. (1993) (6)
- Bidirectional activity and orientation‐dependent specificity of the rat aldolase C promoter in transgenic mice (2001) (5)
- Characterization and metabolic regulation of a liver-specific 5.4-kilobase mRNA whose synthesis is transcriptionally induced by carbohydrates and repressed by glucagon and cyclic AMP. (1985) (5)
- Positive and negative regulation of gene expression by insulin and glucagon: the model of L-type pyruvate kinase gene. (1991) (5)
- 5'-flanking and intragenic sequences confer androgenic and developmental regulation of mouse aldose reductase-like gene in vas deferens and adrenal in transgenic mice. (1999) (5)
- Advances in hereditary red cell enzyme anomalies (2004) (5)
- Phosphorylation of human erythrocyte pyruvate kinase by soluble cyclic-AMP-dependent protein kinases. Comparison with human liver L-type enzyme. (1980) (5)
- Insulin and cyclic AMP act at different levels on transcription of the L‐type pyruvate kinase gene (1997) (5)
- Cellulose acetate electrophoresis of protein kinases: detection of the active forms using various substrates. (1982) (4)
- Glucose-6-phosphate dehydrogenase Velletri. (1977) (4)
- ‘GPI Roma’, a new glucose phosphate isomerase deficient variant (1979) (4)
- Identification of different molecules leading to the formation of hyperanodic forms of human glucose-6-phosphate dehydrogenase. (1981) (4)
- DNA analysis in patients with hereditary fructose intolerance (1984) (4)
- [Erythroleukemia with double erythrocyte population: association in the same population of a weakening in a blood group antigen, a severe adenylate-kinase deficiency and an increase in the A 2 hemoglobin fraction]. (1972) (4)
- A null allele frequent in non-Jewish Tay-Sachs patients (1993) (4)
- Skipping of exon 9 in CFTR mRNA of human adult and fetal pancreas from non-CF individuals. (1993) (4)
- An auxiliary peptide required for the function of two activation domains in upstream stimulatory factor 2 (USF2) transcription factor. (1997) (4)
- The Na‐G Ion Channel Is Transcribed from a Single Promoter Controlled by Distinct Neuron‐ and Schwann Cell‐Specific DNA Elements (1999) (4)
- Hereditary erythrocyte pyruvate-kinase (PK) deficiency and chronic hemolytic anemia: Clinical, genetic and molecular studies in six new Spanish patients (1980) (4)
- The Genes Coding for An-, Ba-, and -y-Chains of Fibrinogen Map to 4q2 (2006) (3)
- G6PD Vientiane: A new glucose-6-phosphate dehydrogenase variant with increased stability (1978) (3)
- Early Steps of a Thymic Tumor in SV40 Transgenic Mice: Hyperplasia of Medullary Epithelial Cells and Increased Mature Thymocyte Numbers Disturb Thymic Export (2002) (3)
- Immunological screening of standard cDNA libraries in pBR322 vectors: detection of human fibrinogen and prothrombin cDNA clones. (1984) (3)
- Independence and interdependence of the three human aldolase A promoters in transgenic mice. (1996) (3)
- Human granulocyte phosphoglycerate kinase. Purification by double affinity elution and immunological study. (1976) (3)
- Using adenoviral vectors to transfer the CNTF gene into the CNS. (1995) (3)
- Stabilization and activation of a human glucose-6-phosphate dehydrogenase variant with enzyme deficiency by specific antibody. (1974) (3)
- Localization of the active gene of aldolase on chromosome 16, and two aldolase A pseudogenes on chromosomes 3 and 10 (1988) (2)
- Muscle-specific transcriptional activation by CArG box requires either homophilic or heterophilic interactions of the CArG box binding factors. (1993) (2)
- Red cell enzymopathies: molecular mechanisms. (1984) (2)
- Analysis byCell-Free Transcription oftheLiver-Specific Pyruvate Kinase GenePromoter (1989) (2)
- Molecular Heterogeneity of MArdle's Disease (1986) (2)
- Control of Hepatic Gene Expression at Both Transcriptional and Posttranscriptional Levels by cAMP (1986) (2)
- [Experimental modulation of apoptosis: physiopathological and therapeutic targets]. (2005) (2)
- Glucose catabolism induces the L-type pyruvate kinase gene (125a). (1996) (2)
- Search for a relationship between molecular anomalies of the mutant erythrocyte pyruvate kinase variants and their pathological expression (2004) (2)
- G-6PD “ankara”. A new G-6PD variant with deficiency found in a Turkish family (2004) (2)
- [Gastrointestinal mastocytosis. Report of a case and review of the literature]. (1973) (2)
- Accuracy of portein synthesis and in vitro aging. Search for altered enzymes in senescent cultured cells from human livers. (1977) (2)
- [Mechanism of decrease in erythrocyte enzyme activities during red cell aging in the newborn and the adult]. (1977) (2)
- Research on molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). Use of new protein mapping and immunological techniques. (1981) (1)
- [Heterogeneity of erythrocytic glucose-6-phosphate dehydrogenase deficiency in negroes. Kinetic study and description of 2 new variants "Gd(-)Dakar and Gd(-)Mali"]. (1971) (1)
- [Molecular aging of human glucose-6-phosphate dehydrogenase]. (1974) (1)
- Glycogenosis Type II (Pompe's Disease): Approach to Gene Therapy Using an Adenovirus Vector. 178 (1996) (1)
- [Haemolytic anaemia due to congenital deffect in phosphohexoseisomerase. Report of a new variant (PHI-Barcelona) with stomatocytosis and increased osmotic fragility (author's transl)]. (1975) (1)
- [Hemolytic congenital nonspherocytic anemia secondary to an erythrocyte glucose-6-phosphate dehydrogenase deficiency. Description of 2 new variants: Gd (-) Saint-Louis (Paris) and Gd (-) Hayem]. (1974) (1)
- Human erythrocyte pyruvate kinase deficiency: The use of a kinetic study of mutant enzymes for the detection of heterozygotes (1978) (1)
- Partial proteolysis of human L-type phosphofructokinase. (1981) (1)
- G6PD deficiency with Gd(-)A like variant in a Chinese family from Cambodia (1979) (1)
- [Hepcidin, the conductor of iron homeostasis]. (2003) (1)
- Transcriptional and Posttranscriptional Regulation of Glycolytic Enzyme Gene Expression in the Liver (1986) (1)
- [Study of hereditary fructose intolerance by methods of molecular biology]. (1985) (1)
- Msp1 RFLP in the human hexosaminidase beta peptide (Hex B) gene. (1989) (1)
- Electrophoretic demonstration of heterozygosis in hereditary pyruvate kinase deficiency (1979) (1)
- [Should acute myeloblastic leukemias be treated in elderly patients?]. (1972) (1)
- Bcl-2 and Bax Modulate Adenine Nucleotide Translocase Activity 1 (2003) (1)
- [Creation of diet-dependent cancer models in transgenic animals]. (1994) (1)
- ‘Gd(-) Hôtel Dieu’: A new G-6PD variant with chronic hemolysis in a Negro patient from Senegal (1977) (1)
- Expression of two aldolase A mRNA species in different human and rat tissues (1986) (1)
- [Leukocytes and erythrocyte GPD deficiency]. (1974) (0)
- [ACTH-secreting tumors. Deregulation of the proopiomelanocortin gene and alterations in processing]. (1988) (0)
- [Immunitary disorders during myeloid splenomegaly with myelofibrosis]. (1972) (0)
- [Treatment of acute myeloblastic leukemia in patients over 60. Apropos of 22 cases]. (1974) (0)
- Functional Characterization oftheL-TypePyruvate Kinase GeneGlucose Response Complex MARIA-JOSEM.DIAZGUERRA,MARIE-ODILEBERGOT,ANTOINEMARTINEZ, (1993) (0)
- Isozyme Pattern in Serially Xenotransplanted Childhood Tumors 1 (2006) (0)
- [Congenital non spherocytic hemolytic anemia due to G-6PD deficiency: physiological and biochemical study of an unusual variant. Relationship to Benevento G-6PD]. (1973) (0)
- Fabry disease: from clinical manifestations to molecular mechanisms (2002) (0)
- [Electrophoresis of erythrocytic 2,3-diphosphoglycerate mutase on amido gel (author's transl)]. (1973) (0)
- Expression of the gene for anti-M\l=u"\llerian hormone (2008) (0)
- [Mechanisms of enzymopathy acquired by the red blood cell during hemopathy]. (1977) (0)
- In vivo Expression of the Murine c-myc Oncogene Driven by the Rat Surfactant Protein A Promoter (1994) (0)
- [Letter: sideroblastic refractory anemias after local cobalt therapy]. (1974) (0)
- Protein ADP-ribosylation in rat liver cytosol. (1983) (0)
- Vanadate increases L-type pyruvate kinase mRNAs level in adult rat hepatocytes in primary culture (1991) (0)
- Therapeutic benefits of cardiotrophin-1 gene transfer in a mouse model of spinal muscular atrophy (2003) (0)
- [The creation of diet-dependent cancer models using transgenesis in animals]. (1994) (0)
- MOUSE-TO-RAT LIVER XENOTRANSPLANTATION USING BCL-2 TRANSGENIC MICE (1999) (0)
- Fast-muscle-specific expression of human aldolase A transgenes (1994) (0)
- recombinant viral vector, pharmaceutical composition thereof and corresponding transformed cells (1995) (0)
- Expression du gène de la proopiomelanocortine en pathologie humaine (1985) (0)
- [Illegitimate transcription: discovery and application to gene molecular pathology]. (1992) (0)
- [Deficiency of red cell glucose-6-phosphate-dehydrogenase due to a slow variant in a French family. Relationship with the Gd (-) Seattle variant (author's transl)]. (1973) (0)
- Erratum: Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs patients (Human Molecular Genetics(1993)2(61-67)) (1993) (0)
- Elements Responsible forHormonal Control andTissue Specificity ofL-TypePyruvate Kinase Gene Expression inTransgenic Mice (1992) (0)
- Using hepcidin for preparing a medicament for treating disorders of iron homeostasis (2002) (0)
- [Biochemical anomalies in blood cells in refractory anemia]. (1974) (0)
- [Kinetic and thermodynamic study of erythrocyte glucose-6-phosphate dehydrogenase in humans. Application to 7 different variants in the negroid race]. (1972) (0)
- [A new case of systemic mastocytosis]. (1972) (0)
- Cell-free synthesis of human prothrombin (1981) (0)
- Advances in Brief Intestinal Dysplasia and Adenoma in Transgenic Mice after Overexpression of an Activated b-Catenin 1 (1999) (0)
- Partial proteolysis of human l-type phosphofructokinase (1981) (0)
- Neuronal expression of enhanced green fluorescent protein directed by 5′ flanking sequences of the rat aldolase C gene in transgenic mice (2003) (0)
- [Genetic polymorphism of erythrocyte 6-PGD: study of 240 black patients, relation to abnormal hemoglobins and description of a new variant]. (1972) (0)
- Identification of three new mutations in the NADH-cytochrome b5 reductase gene responsible for recessive congenital methemoglobinemia type II (1994) (0)
- PADP Ribosylation of human Glucose 6 phosphate dehydrogenase (1981) (0)
- The human pH aldolase A promoter directs widespread but muscle-predominant expression in transgenic mice (1998) (0)
- Expression of brain-specific ID sequence is not restricted to the brain, and a novel complementary cID sequence is found in L-type pyruvate kinase mRNA (a liver-specific messenger) (1986) (0)
- Striking conservation of the brain-specific region of the dystrophin gene (2004) (0)
- Anti-Mullerian hormone Bruxelles : A nonsense mutation associated with the persistent Mullerian duct syndrome ( cDNA polymerase chain reaction / illegtimate transcription / Mullerian-inhibiting substance / sexual differentiation ) (0)
- Brief report Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice (2004) (0)
- Absence of gross defect of fibrinogen genes in one patient with congenital afibrinogenemia (1985) (0)
- Analysis of a Murine Thymic Carcinogenesis Model Induced by the Expression of Large T of SV40 (1997) (0)
- Dystrophin Gene Expression in Neuronal Tissues (1992) (0)
- [Frequency of erythrocyte adenylate-kinase phenotypes in the French population]. (1971) (0)
- Some mechanisms of post translational modification of enzymes (1983) (0)
- [Gene transfer with a therapeutic purpose in the central nervous system]. (1993) (0)
- [Importance and role of imidazole and sulfhydryl groups in the catalytic activity of human erythrocyte glucose-6-phosphate dehydrogenase]. (1972) (0)
- Structural studies on human L' and L pyruvate kinase subunits (1981) (0)
- [Liver repopulation strategies]. (2005) (0)
- [Neo-natal hyperbilirubinemia and G-6-PD Ankara deficiency, a new enzymatic variant discovered in a Turkish family (author's transl)]. (1975) (0)
- Cell-free translation of mRNA from adult and fetal human muscle. Characterization of neosynthesized phosphorylase, phosphofructokinase and glucose phosphate isomerase (1981) (0)
- [Mechanisms of congenital erythrocyte enzyme deficiencies associated with hemolytic anemia]. (1976) (0)
- Molecular heterogeneity of McArdle disease (1986) (0)
- [Recent aspects of the physiopathology of Cushing syndromes: molecular genetics of pro-opiomelanocortin]. (1987) (0)
- [Congenital deficiency in glucose-6-phosphate dehydrogenase. Slow variant found in a Spanish family. Relation with the variant Gd(minus) "Seattle" (author's transl)]. (1974) (0)
- Advances in Brief Hepatomegaly in Transgenic Mice Expressing an Oncogenic Form of b-Catenin 1 (2001) (0)
- Use of hepcidin for the manufacture of a medicament for the treatment of iron homeostasis disorders (2002) (0)
- Production de transferrine par les oligodendrocytes dans le cerveau adulte (1985) (0)
- Two species of messenger RNAs encode liver L and red cell L' pyruvate kinase subunits (1981) (0)
This paper list is powered by the following services:
